Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting, 41321 [2016-15016]
Download as PDF
Federal Register / Vol. 81, No. 122 / Friday, June 24, 2016 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: June 20, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–14919 Filed 6–23–16; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
sradovich on DSK3GDR082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Eunice Kennedy
Shriver National Institute of Child Health
and Human Development Initial Review
Group; Developmental Biology
Subcommittee.
Date: July 19, 2016.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Cathy J. Wedeen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6710B Rockledge Drive,
Room 2121D, Bethesda, MD 20892; (301)
435–6878; wedeenc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
17:43 Jun 23, 2016
Dated: June 20, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–14915 Filed 6–23–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency
Coordinating Committee Meeting
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on July 6–
7, 2016. The subject of the meeting will
be the ‘‘Artificial Pancreas Workshop:
Testing and Adoption of Current and
Emerging Technologies.’’ The meeting is
open to the public.
DATES: The meeting will be held on July
6–7, 2016.
ADDRESSES: The meeting will be held in
the NIH campus, 9000 Rockville Pike,
Bethesda, MD 20892–2560, Lister Hill
Auditorium, Building 38A. Preregistration at https://
www.niddk.nih.gov/news/eventscalendar/Pages/fourth-artificialpancreas-workshop.aspx is required.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
meeting, see the DMICC Web site,
www.diabetescommittee.gov, or contact
Dr. B. Tibor Roberts, Executive
Secretary of the Diabetes Mellitus
Interagency Coordinating Committee,
National Institute of Diabetes and
Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room
9A19, MSC 2560, Bethesda, MD 20892–
2560, telephone: 301–496–6623; FAX:
301–480–6741; email: dmicc@
mail.nih.gov.
SUMMARY:
BILLING CODE 4140–01–P
VerDate Sep<11>2014
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Jkt 238001
The
DMICC, chaired by the National
Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) comprising
members of the Department of Health
and Human Services and other federal
agencies that support diabetes-related
activities, facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
Committee members to learn about and
discuss current and future diabetes
programs in DMICC member
organizations and to identify
opportunities for collaboration. The July
6–7, 2016 DMICC meeting will focus on
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
41321
testing and adoption of current and
emerging artificial pancreas
technologies.
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
person listed on this notice at least 10
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future DMICC meetings should register
for the listserv available on the DMICC
Web site, www.diabetescommittee.gov.
Dated: June 17, 2016.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of
Scientific Program and Policy Analysis,
National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of
Health.
[FR Doc. 2016–15016 Filed 6–23–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5907–N–26]
Federal Property Suitable as Facilities
To Assist the Homeless
Office of the Assistant
Secretary for Community Planning and
Development, HUD.
ACTION: Notice.
AGENCY:
This Notice identifies
unutilized, underutilized, excess, and
surplus Federal property reviewed by
HUD for suitability for use to assist the
homeless.
FOR FURTHER INFORMATION CONTACT:
Juanita Perry, Department of Housing
and Urban Development, 451 Seventh
Street SW., Room 7266, Washington, DC
SUMMARY:
E:\FR\FM\24JNN1.SGM
24JNN1
Agencies
[Federal Register Volume 81, Number 122 (Friday, June 24, 2016)]
[Notices]
[Page 41321]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-15016]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency Coordinating Committee
Meeting
SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee
(DMICC) will hold a meeting on July 6-7, 2016. The subject of the
meeting will be the ``Artificial Pancreas Workshop: Testing and
Adoption of Current and Emerging Technologies.'' The meeting is open to
the public.
DATES: The meeting will be held on July 6-7, 2016.
ADDRESSES: The meeting will be held in the NIH campus, 9000 Rockville
Pike, Bethesda, MD 20892-2560, Lister Hill Auditorium, Building 38A.
Pre-registration at https://www.niddk.nih.gov/news/events-calendar/Pages/fourth-artificial-pancreas-workshop.aspx is required.
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, see the DMICC Web site, www.diabetescommittee.gov, or
contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes
Mellitus Interagency Coordinating Committee, National Institute of
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building
31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496-
6623; FAX: 301-480-6741; email: dmicc@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The DMICC, chaired by the National Institute
of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising
members of the Department of Health and Human Services and other
federal agencies that support diabetes-related activities, facilitates
cooperation, communication, and collaboration on diabetes among
government entities. DMICC meetings, held several times a year, provide
an opportunity for Committee members to learn about and discuss current
and future diabetes programs in DMICC member organizations and to
identify opportunities for collaboration. The July 6-7, 2016 DMICC
meeting will focus on testing and adoption of current and emerging
artificial pancreas technologies.
Any member of the public interested in presenting oral comments to
the Committee should notify the contact person listed on this notice at
least 10 days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present; oral
comments and presentations will be limited to a maximum of 5 minutes.
Printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
Committee by forwarding their statement to the contact person listed on
this notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person. Because of time constraints for the meeting,
oral comments will be allowed on a first-come, first-serve basis.
Members of the public who would like to receive email notification
about future DMICC meetings should register for the listserv available
on the DMICC Web site, www.diabetescommittee.gov.
Dated: June 17, 2016.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy
Analysis, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2016-15016 Filed 6-23-16; 8:45 am]
BILLING CODE 4140-01-P